Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Amino acid-derived lipids
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Amway Herbal Drink
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Skin Laxity
1 trial -
Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Autoimmune Diseases
1 trial -
Anti-infective therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis Adult
1 trial -
Antibiotic selection based on the antibiotic susceptibility testing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastritis
1 trial -
Arbidol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Allergic Rhinitis
1 trial -
Artificial intelligence-assisted chest X-ray in TB screening
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tuberculosis (TB)
1 trial -
Atorvastatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atherosclerosis
1 trial -
Avatrombopag 20 MG Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Aplastic Anemia
1 trial -
Azithromycin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis
1 trial -
Azvudine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
SARS-CoV-2 Infection
1 trial -
BXD treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
IBD - Inflammatory Bowel Disease
1 trial -
Benazepril
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Renal Insufficiency,Chronic
1 trial -
Biobran supplementation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer Stages I
1 trial -
Blinatumomab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
B-ALL
1 trial -
Blinatumomab
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Adult ALL
1 trial -
Bromocriptin 2.5mg, 2-3 times a day
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pituitary Tumor
1 trial -
Bufei Recipe
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Preserved Ratio Impaired Spirometry
1 trial -
Bundle Group 1 with Nutrilite Lifestyle
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoarthritis
1 trial -
Butorphanol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Visceral Pain
1 trial -
Buyang Huanwu Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Glaucoma
1 trial -
CAR-T cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Philadelphia Positive Acute Lymphoblastic Leukemia
1 trial -
CM (Ma-Hsing-Kan-Shih-Tang in combination with Liu-Jun-Zi-Tang)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Childhood Asthma
1 trial -
CM-336 BCMA/CD3 bispecific antibody
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AL Amyloidosis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources